MedTrace Logo

SinuSys Patency of Frontal Recess and Sphenoid Sinus Ostia Study

NCT02463279 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-12-13

No results posted yet for this study

Summary

The goal of this study is to evaluate basic usability and confirm expected safety and effectiveness of SinuSys Dilation System when used to dilate frontal recess and sphenoid sinus ostia in patients with chronic rhinosinusitis.

Conditions

  • Sinusitis

Interventions

DEVICE

Sinusys Dilation System

Dilation of frontal recess and/or sphenoid sinus ostia

Sponsors & Collaborators

  • SinuSys Corporation

    lead INDUSTRY

Principal Investigators

  • Jerome Hester, MD · SinuSys Chief Medical Officer

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-10-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02463279 on ClinicalTrials.gov